Benzothiazinethione is a potent preclinical candidate for the treatment of drug-resistant tuberculosisChao Gao, Yuquan Wei, Tinghong Ye et al.|Scientific Reports|2016Cited by 48
Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivativesCuiting Peng, Luoting Yu, Qian Lei et al.|Bioorganic & Medicinal Chemistry Letters|2015Cited by 45
Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of CancerGuoquan Wan, Luoting Yu, Chang Su et al.|Journal of Medicinal Chemistry|2022Cited by 28
Discovery and evaluation of novel nitrodihydroimidazooxazoles as promising anti-tuberculosis agentsXin Tao, Luoting Yu, Charles Z. Ding et al.|Bioorganic & Medicinal Chemistry Letters|2019Cited by 16
A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine modelsChao Gao, Tinghong Ye, Ningyu Wang et al.|Biomedicine & Pharmacotherapy|2017Cited by 6